National Cancer Institute

Similar documents
Despite the broad advances made in cancer research and interventions

Medical Informatic Basics for the Cancer Registry

Introduction to the National Program of Cancer Registries Modeling Electronic Reporting Project (NPCR-MERP)

Secondary Cancer and Relapse Rates Following Radical Prostatectomy for Prostate-Confined Cancer

Cancer Registries and Medical Records Rich Data Resources

Chapter 6 Case Ascertainment Methods

STATE DOCUMENTATION OF RACIAL AND ETHNIC HEALTH DISPARITIES TO INFORM STRATEGIC ACTION: SUMMARY

Likelihood of Cancer

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for

How To Report A Traumatic Brain Injury In Rhode Island

SPECIAL ARTICLE SUBJECTS AND METHODS

The Ontario Cancer Registry moves to the 21 st Century

Aggregate data available; release of county or case-based data requires approval by the DHMH Institutional Review Board

Health Home Performance Enhancement through Novel Reuse of Syndromic Surveillance Data

Electronic health records to study population health: opportunities and challenges

By: Latarsha Chisholm, MSW, Ph.D. Department of Health Management & Informatics University of Central Florida

CANCER DISPARITIES. A ChartBook

Health Information. Technology and Cancer Information Management. Health Information Technology & Cancer Information Management 363

CASE COMPLETENESS AND DATA QUALITY ASSESSMENTS IN CENTRAL CANCER REGISTRIES AND THEIR RELEVANCE TO CANCER CONTROL

2010 SITE REPORT St. Joseph Hospital PROSTATE CANCER

Graduate Student Epidemiology Program

SUBTITLE D--PROVISIONS RELATING TO TITLE IV SEC GRANTS FOR SMALL BUSINESSES TO PROVIDE COMPREHENSIVE WORKPLACE WELLNESS PROGRAMS

Chapter 21: Managing Abstracting Assignments

Health Disparities in H.R (Merged Senate Bill)

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

Racial Disparities in US Healthcare

RuSH: Sickle Cell Surveillance and Registry Program

Overview of Vital Records and Public Health Informatics in CDPH

Appendix 1. Sociodemographic Characteristics for the Top and Bottom 10 States in the 2009 State Scorecard on Health System Performance

Meaningful Use Stage 2 Certification: A Guide for EHR Product Managers

Electronic Health Records: Why are they important?

COMMUNITY PROFILE REPORT

Dictionary of SEER*Stat Variables November 2011 Submission (released April 2012) 1 of 18

Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data

2. Is the data entered: Manually (i.e. by user) Automatically (i.e. by the ST product) Both

REFERENCE CODE GDHCER PUBLICAT ION DATE JULY 2015 MULTIPLE MYELOMA EPIDEMIOLOGY FORECAST TO 2023

Uncovering Value in Healthcare Data with Cognitive Analytics. Christine Livingston, Perficient Ken Dugan, IBM

Meaningful Use. Goals and Principles

Electronic Health Records: The Intersection of Public Health Surveillance and Clinical Medicine

The Ontario Cancer Registry and its Data Quality. Diane Nishri Senior Research Associate, Surveillance February, 2011

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization N = 50

Cancer Data for South Florida: A Tool for Identifying Communities in Need

Meaningful Use. Medicare and Medicaid EHR Incentive Programs

AAPA ANNUAL SURVEY REPORT

Medical Care Costs for Diabetes Associated with Health Disparities Among Adults Enrolled in Medicaid in North Carolina

THE VIRTUAL DATA WAREHOUSE (VDW) AND HOW TO USE IT

NHCHC Meaningful Use of Electronic Health Records Resource Catalogue. Meaningful Use Overview

Facts about Diabetes in Massachusetts

Chapter 2 History of MD Anderson s Tumor Registry

Find the signal in the noise

Health Information Exchange. Scalable and Affordable

STATISTICAL BRIEF #137

Graduate Student Epidemiology Program

Meaningful Use Stage 2 Administrator Training

PREPARED STATEMENT OF YVONNE T. MADDOX, PH.D. Mr. Chairman and Members of the Committee: I am pleased to present the President s

Accountable Care: Implications for Managing Health Information. Quality Healthcare Through Quality Information

Trends in Asthma Morbidity and Mortality

HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations

Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation

Prostate Cancer. Racial Differences in Prostate Cancer Treatment Outcomes. Prostate Cancer Epidemiology. Prostate Cancer Epidemiology

WILL EQUITY BE ACHIEVED THROUGH HEALTH CARE REFORM? John Z. Ayanian, MD, MPP

Chapter I Overview Chapter Contents

Planning for Health Information Technology and Exchange in Public Health

Secondary Uses of Data for Comparative Effectiveness Research

Chapter 7 Data Quality Management


The Field. Preparation

What is your vision of population/public health practice in an era when the health care of all Americans is supported by EHRs?

Overview. Key Flu Vaccine Coverage Findings. Summary

Environmental Health Science. Brian S. Schwartz, MD, MS

Assessing and Forecasting Population Health

Educational Attainment in the United States: 2003

NPCR Education and Training Series (NETS) Module 3: Quality Control for Central Registries Part 1-Section A: General Overview

THE CHARACTERISTICS OF PERSONS REPORTING STATE CHILDREN S HEALTH INSURANCE PROGRAM COVERAGE IN THE MARCH 2001 CURRENT POPULATION SURVEY 1

Big Data and Oncology Care Quality Improvement in the United States

Find your future in the history

Status Report: Cancer Biomedical Informatics Grid (cabig ) Oversight ad hoc Subcommittee. Board of Scientific Advisors November 7, 2011

The Draft NAACCR XML Data Exchange Standard: Keeping Pace with the New Era in Cancer Surveillance and Research

Public Health Reporting Initiative Functional Requirements Description

Health Information Technology and Cancer Information

Public Health 101 Series

University of Colorado REACH 2012 REACH OVERVIEW. Tim Noe Principal Investigator

The Meaningful Use Stage 2 Final Rule: Overview and Outlook

Colorectal Cancer Screening Behaviors among American Indians in the Midwest

Estimates of New HIV Infections in the United States

Chapter 12: Consolidating Data

LEARNING WHAT WORKS AND INCREASING KNOWLEDGE

How a Vendor-Neutral Archive Can Support You Through Stage 2 Meaningful Use and Beyond

Chapter 13. The hospital-based cancer registry

Note: This article is sponsored by

Eligible Professionals please see the document: MEDITECH Prepares You for Stage 2 of Meaningful Use: Eligible Professionals.

Objectives. ICD Background. Introduction to ICD-10 and what you need to know for a Successful Transition

FCDS Webinar Meaningful Use

Highlights and Trends: ASHA Counts for Year End 2009

Data Analysis and Interpretation. Eleanor Howell, MS Manager, Data Dissemination Unit State Center for Health Statistics

TABLE B5: STAGE 2 OBJECTIVES AND MEASURES

reporting to the Cancer Medical Malware

Reporting Period: For Stage 2, the reporting period must be the entire Federal Fiscal Year.

Diabetes. African Americans were disproportionately impacted by diabetes. Table 1 Diabetes deaths by race/ethnicity CHRONIC DISEASES

Cancer Screening 22M 36% 56% Only 56% of uninsured women aged are up-to-date with mammography screening. Colorectal Cancer Breast Cancer

Transcription:

National Cancer Institute Information Systems, Technology, and Dissemination in the SEER Program U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health

Information Systems, Technology, and Dissemination in the SEER Program http://.seer.cancer.gov The Surveillance, Epidemiology and End Results (SEER) Program is a premier source for cancer statistics in the United States. SEER collects and reports data on incidence, prevalence, and survival from specific geographic areas representing 26 percent of the U.S. population. In addition, SEER reports on cancer mortality for the entire country. SEER is a valuable source of evidence for evaluating cancer prevention and early detection (screening) programs and the quality of cancer care, identifying various risk factors (e.g., environmental, behavioral) related to cancer, documenting disparities, demonstrating the effectiveness of public health interventions, and guiding the translation of research into health policy and practice. To successfully provide these services and resources to the public and the research community, the SEER Program makes extensive use of information systems and technology for both data collection and dissemination. Information systems include various types of people, procedures, data, software, and hardware that are used to gather and analyze information. In a broad sense, the term information systems refers to the interaction between algorithmic processes and technology. This interaction can occur within or across organizational boundaries. An information system is not only the technology an organization uses, but also the way in which the organization interacts with the technology and the way in which the technology works with the organization s business processes. There are various types of information systems. This document provides a brief summary of the information systems and technology used by the SEER Program. SEER Data Management System (SEER*DMS) http://seer.cancer.gov/seerdms The SEER Data Management System (SEER*DMS) is a unified, distributed application used by most SEER Registries. SEER*DMS provides support for all core cancer registry functions: case finding (electronic pathology screening and coding), importing data, editing, abstracting, visual editing, quality control, matching/linkage to existing patient sets, record consolidation (health, supplemental, and other types of records), follow-up/follow-back, rapid case ascertainment, file extraction, tracking, reporting, abstracting, and data security. SEER*DMS is supplied as an appliance solution and includes a hardware/software package. Most enhancements, updates, and upgrades are developed centrally and distributed simultaneously to all locations. The program can be customized at individual locations. For example, SEER*DMS supports site-specific data fields and edits, and choice of matching algorithms. Customization also is facilitated by the modular design of the SEER*DMS workflow. SEER*DMS improves cost efficiency and reduces duplication of effort in system maintenance and administration. In addition, the program ensures data quality and consistency among the various registries by facilitating the collection and reporting of high-quality cancer incidence, treatment, and survival data, and by enabling data sharing among users. Beyond its use by most SEER Registries, SEER*DMS is beneficial to other stakeholders, including SEER affiliates and other organizations (e.g., universities, researchers, public health departments, hospitals). The program is managed and operated by a governing body known as the Change Control Board (CCB), a committee that includes SEER*DMS project staff from NCI and Information Management Services, Inc. (IMS) and registry representatives. In addition, an active SEER*DMS Users Group focuses on best practices, user issues, and enhancements. SEER*DMS was developed by IMS under a Division of Cancer Control and Population Sciences Biomedical Computing Contract (N02-PC-85018-55). SEER Information Systems, Technology, and Dissemination in the SEER Program 1

Electronic Pathology (E-Path) Software http://www.aim.on.ca/products/epath.jsp Annually Updated Statistical Reports Electronic Pathology (E-Path) supports and facilitates the process of efficiently collecting complete and accurate pathology information from numerous hospital-based and freestanding pathology laboratories that report to SEER s centrally based cancer registries. In its basic form, E-Path reports cancers that are diagnosed through histology, which comprise about 95 percent of all cancers. The scope of casefinding can be extended by integrating E-Path with other types of electronic records, such as other laboratory results (e.g., diagnostic imaging, hematology) or admission, discharge, and transfer (ADT) information. Cancer registries rely heavily on pathology reports to identify new cases and determine key characteristics of a cancer required for its classification standards. Using information technology to standardize and automate this process is cost effective, labor saving, and reduces errors when compared to handson methods. E-Path uses an automated ICD-03 SEER Web Dissemination coding assistant in conjunction with natural language processing technology and pathology-specific terminology to automatically identify, index, abstract, and codify potentially reportable cancers from text-based reports. Cases then can be transmitted electronically from the pathology laboratory to the registry, increasing both the timeliness of case reporting and the quality of information transmitted. Electronic Pathology software is supplied to the SEER Program under a contract with Artificial Intelligence in Medicine, Inc. (AIM). E-Path is provided to all SEER Registries and their major reporting laboratories and has been implemented in more than 200 reporting hospitals and laboratories in Atlanta, Connecticut, Detroit, Greater California, Hawaii, Iowa, Kentucky, Los Angeles, Louisiana, New Jersey, New Mexico, Northern California, and Utah. http://seer.cancer.gov SEER Cancer Statistics Review (CSR), 1975 2006. Also known as CSR, this searchable online report, available at http://seer.cancer.gov/csr, includes tables showing cancer statistics by race, sex, age, and year of diagnosis for the major cancer sites and for all cancers combined. Annual Report to the Nation on the Status of Cancer. Staff from the National Cancer Institute (NCI), the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the North American Association of Central Cancer Registries (NAACCR), and Special Reports An Update on Cancer in American Indians and Alaska Natives, 1999 2004. This supplemental monograph, available at http://seer.cancer.gov/publications/aian, provides a comprehensive description of the cancer burden in the American Indian/Alaska Native population in the United States. The report gives medical providers and the public information about challenges faced by this ethnic group and promotes further research designed to improve survival and quality of life for members of this community. other experts collaborate to provide an annual update on cancer occurrence and trends in the United States. Available at http://seer.cancer.gov/report_to_nation. United States Cancer Statistics, 1999-20xx, Cancer Incidence and Mortality Data. A Web-based report, available at http://apps.nccd.cdc.gov/uscs, makes highquality cancer incidence and mortality data available to the general public. Staff from the CDC, SEER Registries, and NAACCR collaborate to ensure that the most up-todate data are provided on this Web site. Cancer Incidence and Mortality Patterns among Specific Asian and Pacific Islander Populations in the U.S. This statistical report, http://seer.cancer.gov/publications/apicancer, focuses on cancer incidence, mortality, and stage distributions among Asians and Pacific Islanders (API) residing in the United States. Health disparities are reported using the cancer experience of the non-hispanic white population as the referent group. Through its Web site, http://seer.cancer.gov, the SEER Program provides interested users access to a variety of resources, including statistical tables, graphs, maps, data sets, tools, software, and publications. SEER data are accessed and used by thousands of researchers, clinicians, cancer registrars, public health officials, legislators, policymakers, community groups, and members of the public. The SEER Web site serves as an authoritative source of information for anyone interested in U.S. cancer statistics, cancer research activities, and cancer surveillance methods. The materials available through the Web site are produced by the SEER Program or through collaborative efforts between SEER and affiliated organizations. Selected Comparisons of Measures of Health Disparities: A Review Using Databases Relevant to Healthy People 2010 Cancer-Related Objectives. This monograph, available at http://seer.cancer.gov/publications/disparities2, presents results from 22 separate analyses in 10 case studies and includes assessments of socioeconomic, racial, ethnic, and geographic disparities in a range of cancer-related outcomes such as mortality, incidence, risk factors, and screening. The report demonstrates that choosing particular methods to measure health disparities can make a substantive difference in the results and interpretation of data. The Web version of this monograph is 508 compliant. SEER Information Systems, Technology, and Dissemination in the SEER Program SEER Information Systems, Technology, and Dissemination in the SEER Program 2 3

Special Reports (continued) SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988 2001, Patient and Tumor Characteristics. This monograph examines cancer survival with regard to patient and tumor characteristics. The data represent cancer in approximately 25 percent of the U.S. population. Patient characteristics include age, race, and sex. Tumor characteristics vary by cancer site and may include subsite, size of tumor, extension of the tumor, lymph nodes positive, distant metastases, and histologic type. Cancer Mortality Maps & Graphs. This Web site shows geographic patterns and cancer death rate trends for more than 40 cancers for the time period 1950 1994. Go to http://seer.cancer.gov/statistics and click on the Cancer Mortality & Graphs link. Click on the Cancer Mortality Maps & Graphs Web site link and then Interactive Mortality Charts and Graphs and Customizable Mortality Maps to create maps such as this one by choosing from the variables shown. Up-to-Date Web-Based Cancer Statistics Cancer Stat Fact Sheets. The Cancer Stat Fact Sheets are a collection of statistical summaries for various common cancer types. Go to http://seer.cancer.gov/statfacts to access Cancer Stat Fact Sheets such as this one for myeloma. http://seer.cancer.gov/statfacts/html/mulmy.html Fast Stats. The Fast Stats interactive tool links to tables, charts, and graphs containing cancer statistics for all major cancer sites by age, sex, race, and time period. Go to http://seer.cancer.gov/statistics and click on the Fast Stats link to create a chart such as this by choosing from the variables listed. For information on additional published reports and statistical monographs, visit http://seer.cancer.gov/publications or the searchable SEER Bibliography at http://seer.cancer.gov/pubsearch. The SEER Bibliography Cancer Query Systems. The Cancer Query Systems dataretrieval applications, available at http://seer.cancer.gov/ canques/index.html, provide more flexibility and a larger set of cancer statistics than Fast Stats, but also require more user input. State Cancer Profiles. State Cancer Profiles are a comprehensive system of dynamic maps and graphs that enable the investigation of cancer trends at the national, state, and county levels. The SEER Bibliography, available at http://seer.cancer. gov/pubsearch, is a comprehensive bibliography of SEER publications produced by registry and program staff. As of the fall of 2009, approximately 6,000 SEER publications were available via the SEER Bibliography. http://seer.cancer.gov/canques/incidence.html http://statecancerprofiles.cancer.gov/micromaps SEER Information Systems, Technology, and Dissemination in the SEER Program SEER Information Systems, Technology, and Dissemination in the SEER Program 4 5

Access to Datasets and Tools SEER releases limited-use data files, SEER*Stat analytical software, the HD*Calculator, and the SEER Bibliography, all of which are made available to the public via the SEER Web site. These data and software tools can be used to address issues in cancer research. SEER*Stat. SEER*Stat statistical software provides a convenient, intuitive mechanism for analyzing SEER and other cancer-related databases. It is a powerful personal computer tool for producing statistics for use in studying the impact of cancer on a population. Available at: http:// seer.cancer.gov/seerstat HD*Calc. This statistical software generates multiple summary measures for evaluating and monitoring health disparities. HD*Calc can be used either as an extension of SEER*Stat or on its own with other population-based health data. Data such as cancer rates, survival, and stage at diagnosis can be used with HD*Calc to generate absolute and relative summary measures of disparity. Available at: http://seer.cancer.gov/hdcalc SEER and the Biomedical Informatics Grid The Cancer Biomedical Informatics Grid, known as cabig, was launched by NCI s Center for Bioinformatics (NCICB) in February 2004. The goal of cabig is to accelerate the development of new approaches for the prevention, detection, diagnosis, and treatment of cancer in the United States by developing a collaborative network of informatics infrastructures, tools, and ideas that SEER*Prep. SEER*Prep is used to convert user-supplied ASCII text data files to the SEER*Stat database format, allowing analysis of population-based registry data using SEER*Stat. Available at: http://seer.cancer.gov/seerprep SEER also provides various analytic software tools that have been developed for the analysis and reporting of cancer statistics. More information about these tools can be found at http://seer.cancer.gov/resources. http://srab.cancer.gov/software http://cabig.cancer.gov enables the collection, analysis, and sharing of data and knowledge along the entire research pathway, from the laboratory bench to the patient s bedside. cabig encourages networking through the development of open access and open-source software, applications, tools, and database technologies. Since its debut, cabig has expanded to include cancer centers and numerous other NCI-supported research endeavors. Researchers are developing software and networks that will make other cancer-related databases and networks (i.e., SEER) more accessible on the cabig Grid. CaSEER: SEER Data on the Grid Through cabig, the SEER Program is able to link its data to other cancer-related databases and networks and provide researchers with access to information and interactive tools that are essential for cancer surveillance. By combin Future Directions for SEER The SEER Program aims to become more efficient and effective at data collection by facilitating the expansion, standardization, and interoperability of its data sources and electronic reporting capabilities. Currently, the SEER Program has four priority data areas for electronic reporting: 1. Diagnosis 2. Comorbidities 3. Detailed treatment 4. Electronic radiology data Future sources for collecting and coding electronic data may include Health Maintenance Organizations (HMOs), including the Cancer Research Network For more information, contact: Dave Stinchcomb, M.A., M.S. Chief, Surveillance Systems Branch Surveillance Research Program Division of Cancer Control and Population Sciences National Cancer Institute stinchcd@mail.nih.gov 301-594-7251 6116 Executive Boulevard #5023 Bethesda, MD 20892-8334 ing its resources with other databases on the grid, SEER contributes to the development of common standards such as shared vocabulary, data elements, data models, analytical services, and interoperable applications. (CRN), their affiliated research programs and staff, enrolled patient populations, and data systems. Access to these entities will facilitate timely access to the electronic health records of numerous doctors, pathologists, radiologists, primary care providers, and other medical entities. Collaboration with other networks, such as cabig, the Centers for Medicare and Medicaid Services (CMS), hospitals, and other similar resources, also will expedite the SEER Program s ongoing efforts to capture, compile, and process medical data in an efficient manner. This data will enable the SEER program to more effectively conduct studies on access to care, cancer prevention, early detection, treatment, long-term care, outcomes, and other important cancer-related issues. SEER Information Systems, Technology, and Dissemination in the SEER Program SEER Information Systems, Technology, and Dissemination in the SEER Program 6 7

4 April 2010